Literature DB >> 21752570

An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis.

Richard W Martin1, Matthew E Brower, Alexander Geralds, Patience J Gallagher, Donald J Tellinghuisen.   

Abstract

OBJECTIVE: To explore how effectively information presentation formats used in a patient decision aid communicated the ability of a disease modifying anti-rheumatic drug to slow the rate of progression of rheumatoid arthritis related structural joint damage (SJD).
METHODS: 91 first year psychology students and 91 RA patients participated in a prospective randomized, single blind, factorial experimental design evaluating the effect of four information formats on: satisfaction with risk communication, verbatim and gist recall of a hypothetical anti-rheumatic drug's ability to slow the rate of progression of SJD.
RESULTS: Both groups underestimated the hypothetical drug's ability to slow SJD. Formats that supported the narrative statement with a reinforcing graphic element resulted in recall closer to the true value. Comparison of the results from testing of RA patients and college students were remarkably similar across formats.
CONCLUSION: Rate of progression as communicated by narrative statement plus a graphic element (i.e. speedometer metaphor or pictograph) aided recall better than a narrative statement alone. Our results suggest that testing decision aid components with non-patients may provide data generalizable to patient populations. PRACTICE IMPLICATIONS: Graphics must be used carefully in patient decision aids as they can enhance recall, but may also introduce unintended recall bias. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752570     DOI: 10.1016/j.pec.2011.06.001

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  11 in total

1.  Preference Phenotypes in Support of Shared Decision-Making at Point-of-Care for Patients With Rheumatoid Arthritis: A Proof-of-Concept Study.

Authors:  Betty Hsiao; Pauline Binder-Finnema; W Benjamin Nowell; George Michel; Carole Wiedmeyer; Liana Fraenkel
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-04-08       Impact factor: 4.794

2.  Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.

Authors:  Jennifer G McIntosh; Jesse Minshall; Sibel Saya; Adrian Bickerstaffe; Nadira Hewabandu; Ashleigh Qama; Jon D Emery
Journal:  Br J Gen Pract       Date:  2019-11-28       Impact factor: 5.386

Review 3.  Medication Risk Communication in Rheumatology: Where Are We and Where Do We Go from Here?

Authors:  Susan J Blalock
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

4.  Rheumatoid Arthritis Patients' Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens.

Authors:  Yomei Shaw; Ilinca D Metes; Kaleb Michaud; Julie M Donohue; Mark S Roberts; Marc C Levesque; Judy C Chang
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-03-11       Impact factor: 4.794

5.  English language proficiency, health literacy, and trust in physician are associated with shared decision making in rheumatoid arthritis.

Authors:  Jennifer L Barton; Laura Trupin; Chris Tonner; John Imboden; Patricia Katz; Dean Schillinger; Edward Yelin
Journal:  J Rheumatol       Date:  2014-07       Impact factor: 4.666

6.  The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter.

Authors:  Jennifer L Barton; Christopher J Koenig; Gina Evans-Young; Laura Trupin; Jennie Anderson; Dana Ragouzeos; Maggie Breslin; Timothy Morse; Dean Schillinger; Victor M Montori; Edward H Yelin
Journal:  BMC Med Inform Decis Mak       Date:  2014-11-25       Impact factor: 2.796

7.  Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis.

Authors:  Richard W Martin; Ryan D Enck; Donald J Tellinghuisen; Aaron T Eggebeen; James D Birmingham; Andrew J Head
Journal:  Med Decis Making       Date:  2017-03-15       Impact factor: 2.583

8.  Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug.

Authors:  Richard W Martin; Kelsey McCallops; Andrew J Head; Aaron T Eggebeen; James D Birmingham; Donald J Tellinghuisen
Journal:  BMC Med Inform Decis Mak       Date:  2013-08-12       Impact factor: 2.796

Review 9.  Providing information about options in patient decision aids.

Authors:  Deb Feldman-Stewart; Mary Ann O'Brien; Marla L Clayman; B Joyce Davison; Masahito Jimbo; Michel Labrecque; Richard W Martin; Heather Shepherd
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-29       Impact factor: 2.796

Review 10.  Balancing the presentation of information and options in patient decision aids: an updated review.

Authors:  Purva Abhyankar; Robert J Volk; Jennifer Blumenthal-Barby; Paulina Bravo; Angela Buchholz; Elissa Ozanne; Dale Colins Vidal; Nananda Col; Peep Stalmeier
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-29       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.